Vitamed Biomedical S.r.l.

Vendita dispositivi medici

Home CerviCare for healthcare workers

CerviCARE® AI

The new frontier in cervical cancer screening powered by Artificial Intelligence

CerviCARE® AI is an AI-based cervical cancer screening system designed to support early diagnosis of precancerous cervical lesions. It uses a deep learning algorithm trained on a clinical database of over 7 million cervical images (collected over 28 years) to analyze cervicographic images captured via a portable device, providing fast and accurate results.

CerviCARE AI

Key benefits:

  • High diagnostic accuracy: 98% sensitivity and 95.5% specificity in detecting high-risk lesions (HSIL, CIN2 or above).*
  • Fast analysis: Delivers results in under 5 seconds after image acquisition.
  • Portable device: Lightweight and easy to use, requiring no complex infrastructure or Wi-Fi.
  • Simple procedure: Application of 5% acetic acid, image capture, and automatic analysis.
  • Decision support: Generates detailed reports for patient consultation and can integrate with telemedicine systems for specialist reviews.

*Data validated on international cohorts and published in Scientific Reports, 2024:
read the article

How it supports real-time clinical decision-making:

  • Reduces initial diagnostic time from weeks to minutes, helping the specialist immediately determine the next step.
  • Allows immediate identification of high-risk cases, avoiding loss to follow-up and clinical delays.
  • The specialist always retains control over clinical decisions: CerviCARE® AI does not replace official tests, but integrates and anticipates them.
  • If the result is negative, the specialist may still confirm it with a Pap test or HPV test for greater safety.
  • In cases of atypia or high-grade lesions, the specialist can act promptly, improving the patient’s prognosis.
CerviCARE AI screenshot

Technology serving health

High-definition imaging and artificial intelligence work together to provide immediate, objective clinical responses, reducing waiting times and improving risk management.

CerviCARE® AI classifies each acquired image into one of the following 4 categories:

  • Normal: Routine check-up or Pap test/HPV test at the specialist’s discretion.
  • Atypical: Pap test or HPV test.
  • Abnormal Low: Colposcopy with biopsy.
  • Abnormal High: Urgent colposcopy, biopsy, and referral to oncology center if confirmed.
ogo-wtihbg-en
download PDF